21013 ⎘
Medicinal preparations containing peptides; Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans Albumins
Sub-classes:NUTRITIONAL FORMULA
#2GLYCOTARGETING THERAPEUTICS
#3A COMPLEX COMPRISING A ALPHA-LACTALBUMIN AND A FATTY ACID OR LIPID FOR USE IN THE TREATMENT OR PREVENTION OF CANCER
#4ENRICHMENT AND CHANNELING OF PLURIPOTENT CELLS BY PROTEIN NANOPARTICLES
#5Nutritive Polypeptides and Formulations Thereof, and Methods of Production and Use Thereof
#6GLYCOTARGETING THERAPEUTICS
#7COMPOSITION FOR THE USE IN THE TREATMENT OF POLYCYSTIC OVARY SYNDROME
#8GLYCOTARGETING THERAPEUTICS
#9HOLLOW SPHERICAL PARTICLES
#10METHODS FOR TREATMENT OF COGNITIVE IMPAIRMENT IN CIRRHOSIS PATIENTS
#11Cancer-Targeted Alpha-Particle Therapeutic Vehicles For Treatment Of Cancer
#12GLYCOTARGETING THERAPEUTICS
#13METHODS AND COMPOSITIONS FOR DETOXIFICATION OF CHRONIC EXPOSURE TO TOXINS
#14METHODS OF TREATING EPITHELIOID CELL TUMORS
#15METHODS AND PRODUCTS FOR NUCLEIC ACID PRODUCTION AND DELIVERY
#16METHOD FOR TREATING TUMOR USING IMMUNE CELL
#17PHARMACEUTICAL OR FODD SUPPLEMENT FORMULATION CONTAINING ALPHA-LACTALBUMIN AND BUTYRIC ACID OR A SALT THEREOF
#18COMPOSITIONS COMPRISING THEANINE, MAGNOLIA, AND PHELLODENDRON
#19SYSTEMS FOR EXTRACTING PROTEINS FROM A BLOOD-BASED MATERIAL
#20PREPARATION OF A THERAPEUTIC COMPOSITION FOR TREATING AUTOIMMUNE DISEASES
#21METHODS AND COMPOSITION OF INHIBITING ASPROSIN MEDIATED OREXIGENESIS AND/OR GLUCOGENSIS
#22GLP-1R AGONISTS FOR USE IN A TREATMENT OF NEUROLOGIAL IMPAIRMENT ASSOCIATED WITH VIRAL INFECTION
#23METHOD OF TREATING PATIENTS WITH HEPATORENAL SYNDROME TYPE 1
#24METHOD OF TREATING PATIENTS WITH HEPATORENAL SYNDROME TYPE 1
#25METHOD OF TREATING PATIENTS WITH HEPATORENAL SYNDROME TYPE 1
#26METHOD OF TREATING PATIENTS WITH HEPATORENAL SYNDROME TYPE 1
#27Blood Plasma Fractions for Use in Muscle Regeneration
#28COMPOSITIONS FOR TREATING MACULAR EDEMA
#29THERAPEUTIC RNA FOR TREATING CANCER
#30TOLEROGENIC SYNTHETIC NANOCARRIERS FOR ALLERGY THERAPY
#31METHODS FOR EFFECTIVE AND SAFE TREATMENT OF NEUTROPENIA USING DE-MOBILIZED G-CSF
#32METHOD OF TREATING PATIENTS WITH HEPATORENAL SYNDROME TYPE 1
#33TISSUE CULTURE MEDIA FOR SURVIVAL AND ENGRAFTMENT OF HUMAN PANCREATIC ISLETS
#34USE OF THERAPEUTIC PLASMA EXCHANGE AND LOW VOLUME PLASMA EXCHANGE FOR THE TREATMENT OF A COGNITIVE IMPAIRMENT
#35POLYOXAZOLINE-BOUND ALBUMIN, ARTIFICIAL PLASMA EXPANDER, AND HEMORRHAGIC SHOCK RESUSCITATION FLUID
#36USE OF ALBUMIN FOR THE TREATMENT OF DEFECTIVE B-CELL FUNCTION
#37TOLEROGENIC SYNTHETIC NANOCARRIERS
#38PROPHYLACTIC AND NUTRACEUTICAL THERAPY
#39COMPOSITIONS AND METHODS RELATED TO IMMUNOGLOBULIN PROTEASES AND FUSIONS THEREOF
#40COMPOSITION FOR TREATING CANCER EXPRESSING SPARC
#41PROLYL HYDROXYLASE DOMAIN INHIBITOR TREATMENT TO IMPROVE SURVIVABILITY OF HEMORRHAGIC SHOCK
#42USE OF LOW VOLUME PLASMA EXCHANGE FOR TREATING THE EARLY AND MIDDLE STAGES OF ALZHEIMER'S DISEASE
#43Low-toxicity and high-efficiency orthoester mixture pharmaceutical adjuvant, preparation method thereof, and topical sustained release drug delivery formulation including same
#44DUAL-ADMINISTRATION METHODS FOR TREATING RESPIRATORY DISTRESS
#45COMPOSITIONS AND METHODS FOR TREATING PERIPHERAL ARTERY DISEASE
#46METHOD FOR PREPARING A COMPOSITION COMPRISING AN UNFOLDED PROTEIN
#47TOLEROGENIC SYNTHETIC NANOCARRIERS TO REDUCE IMMUNE RESPONSES TO THERAPEUTIC PROTEINS
#48TOLEROGENIC SYNTHETIC NANOCARRIERS TO REDUCE ANTIBODY RESPONSES
#49COMPLEXES FOR THE DELIVERY OF PROTEINACEOUS AGENTS
#50TOLEROGENIC SYNTHETIC NANOCARRIERS FOR ALLERGY THERAPY
#51Use of Plasma and Plasma Fractions for Improvement of Pain, Wound Healing, and Postoperative Recovery
#52INFANT FORMULA MILK POWDER RICH IN MILK FAT GLOBULE MEMBRANE PROTEIN, PHOSPHOLIPIDS AND OLIGOSACCHARIDES AND PREPARATION METHOD THEREFOR
#53Extracellular Vesicles and Compositions Thereof
#54PROTEIN NANOSPHERES TO TREAT HARM FROM MULTIPLE TRAUMA
#55PROTEOPHOSPHOLIPOSOMES HAVING HDL-TYPE VESICLES
#56Nutritional formula
#57SUBCUTANEOUS ADMINISTRATION OF FACTOR VIII
#58HIGH CONCENTRATED PROTEIN COMPOSITIONS FOR PREVENTING TISSUE ADHESION
#59EGG PROTEIN FORMULATIONS AND METHODS OF MANUFACTURE THEREOF
#60Compositions comprising theanine, magnolia, and phellodendron
#61NUTRITIONAL FORMULA
#62EGG PROTEIN FORMULATIONS AND METHODS OF MANUFACTURE THEREOF
#63METHODS AND COMPOSITIONS FOR IMPROVING KIDNEY FUNCTION IN PATIENTS WITH HEPATORENAL SYNDROME
#64GLYCOTARGETING THERAPEUTICS
#65GLYCOTARGETING THERAPEUTICS
#66Use of Plasma and Plasma Fractions for Improvement of Pain, Wound Healing, and Postoperative Recovery
#67METHODS AND COMPOSITIONS FOR IMPROVING KIDNEY FUNCTION IN PATIENTS WITH HEPATORENAL SYNDROME
#68GLYCOTARGETING THERAPEUTICS
#69Methods For Treating Coronavirus Disease
#70GLYCOTARGETING THERAPEUTICS
#71METHODS FOR TREATING INFLAMMATORY CONDITIONS OF THE LUNGS
#72METHODS AND COMPOSITIONS FOR IMPROVING KIDNEY FUNCTION IN PATIENTS WITH HEPATORENAL SYNDROME
#73COMPOSITIONS AND METHODS WITH A PROBIOTIC AND A N-3 FATTY ACID FOR THE PREVENTION OR TREATMENT OF MASTITIS
#74COMPOSITIONS AND METHODS WITH A PROBIOTIC AND A NUTRIENT AND/OR MINERAL FOR THE PREVENTION OR TREATMENT OF MASTITIS
#75Methods for Extracting Proteins from a Blood-Based Material
#76USE OF ALPHA-LACTALBUMIN ENRICHED WHEY PROTEIN EXTRACT AS A SOURCE OF CHOLESTEROL
#77A composition for boosting the immune system
#78Detection of a defect on HLA-E restricted CD8+ T regulatory cells
#79Method for treating type I diabetes with peptide-loaded dendritic cells
#80Method for treating multiple sclerosis with peptide-loaded dendritic cells
#81Blood plasma fractions for use in muscle regeneration
#82METHODS FOR PROVIDING POLYMERIC SYNTHETIC NANOCARRIERS FOR GENERATING ANTIGEN-SPECIFIC TOLERANCE IMMUNE RESPONSES
#83COMPOSITION FOR TREATING CANCER EXPRESSING SPARC
#84SYNTHETIC NANOCARRIERS COMPRISING AN IMMUNOSUPPRESSANT IN COMBINATION WITH HIGH AFFINITY IL-2 RECEPTOR AGONISTS TO ENHANCE IMMUNE TOLERANCE
#85COMBINATION OF A CHEMOTHERAPEUTIC AGENT AND ALPHA-LACTOGLUBULIN-OLEIC ACID COMPLEX FOR CANCER THERAPY
#86PARA-AMINOHIPPURIC ACID (PAH) AS A RENAL PROTECTIVE SUBSTANCE
#87EXTENDED-RELEASE DRUG DELIVERY COMPOSITIONS
#88C3 FUSION PROTEIN AND METHODS OF MAKING AND USING THEREOF
#89USE OF WHEY PROTEIN MICELLES FOR CONTROLLING POSTPRANDIAL GLUCOSE RESPONSE
#90COMPOSITIONS COMPRISING ALBUMIN-FMS-LIKE TYROSINE KINASE 3 LIGAND FUSION PROTEINS AND USES THEREOF
#91APPLICATION OF TRANSTHYRETIN IN ENTERING EYE AND PREPARING DROP
#92FORMULATIONS FOR NUTRITIONAL SUPPORT IN SUBJECTS IN NEED THEREOF
#93METHOD OF TREATING PATIENTS WITH HEPATORENAL SYNDROME TYPE 1
#94COMPOSITION COMPRISING ALBUMIN-COUPLED SLIT3 LRRD2 FOR PREVENTION OR TREATMENT OF MUSCLE DISEASE
#95Long-acting GLP-1r agonist as a therapy of neurological and neurodegenerative conditions
#96NUTRITIONAL COMPOSITION FOR INDUCING A FEELING OF SATIETY, A BETTER SLEEP AND/OR LIMITING NOCTURNAL AWAKING IN INFANTS OR YOUNG CHILDREN
#97COMPOSITIONS, USES AND METHODS FOR TREATMENT OF INFERTILITY AND SUBFERTILITY
#98HUMAN MILK FORTIFIER COMPOSITION
#99USE OF LOW VOLUME PLASMA EXCHANGE FOR TREATING THE EARLY AND MIDDLE STAGES OF ALZHEIMER'S DISEASE
#100NUTRITIONAL SUPPLEMENTS FOR ANIMAL HEALTH AND DEVELOPMENT
#101Native whey protein for treating and/or preventing intestinal infection
#102DRUG CONJUGATE PREPARED USING ALDEHYDE GROUP AT END OF HYALURONIC ACID
#103SELECTIVELY CLEAVABLE THERAPEUTIC NANOPARTICLES
#104Nutritional formula
#105COMPOSITIONS AND METHODS FOR MEASURING AND EXPANDING BLOOD VOLUME
#106Pharmaceutical or food supplement preparation based on alpha-lactalbumin
#107COMPOSITIONS AND METHODS FOR THE TREATMENT OF MASTITIS
#108IDENTIFICATION AND TREATMENT OF TUMORS CHARACTERIZED BY AN OVEREXPRESSION OF THE NEONATAL FC RECEPTOR
#109TREATMENT OF JOINT CONDITIONS
#110Methods of treating epithelioid cell tumors
#111METHOD OF TREATING PATIENTS WITH HEPATORENAL SYNDROME TYPE 1
#112Methods for extracting proteins from a blood-based material
#113Stem cell stimulating compositions for treatment of melasma
#114BIODEGRADABLE AND CLINICALLY-COMPATIBLE NANOPARTICLES AS DRUG DELIVERY CARRIERS
#115WHEY PROTEIN CONCENTRATE IN ASSOCIATION WITH ANTITUMOUR TREATMENT
#116Cationic materials and formulations for drug delivery
#117MODIFIED RNA WITH DECREASED IMMUNOSTIMULATORY PROPERTIES
#118Medical organogel processes and compositions
#119Human milk fortifier composition
#120Methods of inducing liver regeneration by administering a plasma protein fraction
#121FORMULATIONS FOR NUTRITIONAL SUPPORT IN SUBJECTS IN NEED THEREOF
#122C3 fusion protein and methods of making and using thereof
#123Compositions comprising theanine, s-adenosylmethionine (SAMe), and/or and
#124Blood plasma fractions for use in muscle regeneration
#125METHOD OF TREATING PATIENTS WITH HEPATORENAL SYNDROME TYPE 1 AND LOW MEAN ARTERIAL PRESSURE
#126METHOD OF DELIVERING DRUGS TO INNER EAR FACILITATED BY MICROBUBBLES
#127Methods of treating a subject for pain
#128Nanospheres for bone fracture
#129CANCER TREATMENTS
#130Factor IX polypeptides and methods of use thereof
#131FACTOR IX POLYPEPTIDES AND METHODS OF USE THEREOF
#132Clotting composition
#133Emulsion adjuvant for intramuscular, intradermal and subcutaneous administration
#134Nutritive polypeptides and formulations thereof, and methods of production and use thereof
#135INTRAVASCULAR DELIVERY OF NANOPARTICLE COMPOSITIONS AND USES THEREOF
#136HYDROPHOBIC ION PAIRING AND FLASH NANOPRECIPITATION FOR FORMATION OF CONTROLLED-RELEASE NANOCARRIER FORMULATIONS
#137Compositions for treating macular edema
#138METHOD OF TREATING PATIENTS WITH HEPATORENAL SYNDROME TYPE 1
#139METHOD OF TREATING PATIENTS WITH HEPATORENAL SYNDROME TYPE 1
#140System, Method and Compositions for Treating Age-Related Illnesses and Conditions
#141Phosphoserine containing compositions for immune tolerance induction
#142Compositions, uses and methods for treatment of infertility and subfertility
#143Container for a solution of human plasma proteins and method for obtaining thereof
#144Low concentrated protein compositions for preventing tissue adhesion
#145High concentrated protein compositions for preventing tissue adhesion
#146Nutritive Polypeptides and Formulations Thereof, and Methods of Production and Use Thereof
#147Non-immunogenic protein nanoparticles with cancer targeting activity using albumin-binding peptide
#148CATIONIC MATERIALS AND FORMULATIONS FOR DRUG DELIVERY
#149Glycotargeting therapeutics
#150Glycotargeting therapeutics
#151Glycotargeting therapeutics
#152Methods of improving wound healing
#153Methods of improving or accelerating postoperative recovery
#154Glycotargeting therapeutics
#155Methods for treatment of nephrotic syndrome and related conditions
#156TOLEROGENIC SYNTHETIC NANOCARRIERS FOR GENERATING CD8+ REGULATORY T CELLS
#157TOLEROGENIC SYNTHETIC NANOCARRIERS FOR ANTIGEN-SPECIFIC DELETION OF T EFFECTOR CELLS
#158Methods and products for nucleic acid production and delivery
#159METHOD OF TREATING PATIENTS WITH HEPATORENAL SYNDROME TYPE 1
#160Compositions and methods for measuring and expanding blood volume
#161Treatment of joint conditions
#162Formulations for Nutritional Support in Subjects in Need Thereof
#163Patterned electrospun fibers for tissue engineering
#164Methods for treating inflammatory conditions of the lungs
#165Nanoparticles for the therapeutic treatment of radiation-induced skin ulcers
#166METHOD OF TREATING PATIENTS WITH HEPATORENAL SYNDROME TYPE 1
#167Lactoferrin/albumin fusion protein and production method therefor
#168Compositions comprising theanine and whey protein
#169Prophylactic and nutraceutical therapy
#170BIODEGRADABLE MICROBEADS WITH IMPROVED ANTICANCER DRUG ADSORPTIVITY, CONTAINING ALBUMIN AND DEXTRAN SULFATE, AND PREPARATION METHOD THEREFOR
#171Nutritional formula
#172Egg protein formulations and methods of manufacture thereof
#173Opioid agonist peptides and uses thereof
#174EXTENDED-RELEASE DRUG DELIVERY COMPOSITIONS
#175Compositions comprising albumin-FMS-like tyrosine kinase 3 ligand fusion proteins and uses thereof
#176BLOCKADE OF ALPHAFETOPROTEIN (AFP) INTERACTIONS WITH BETA2-MICROGLOBULIN ASSOCIATED MOLECULES
#177Combination with albumin, in particular for treating a cartilage defect
#178Factor IX polypeptides and methods of use thereof
#179Factor IX polypeptides and methods of use thereof
#180Compositions and methods of use for treating metabolic disorders
#181ACTIVE SELF-HEALING BIOMATERIAL SYSTEM
#182INTRAVASCULAR DELIVERY OF NANOPARTICLE COMPOSITIONS AND USES THEREOF
#183Soluble glycoprotein V for treating thrombotic diseases
#184Formulations for nutritional support in subjects in need thereof
#185HUMAN SERUM ALBUMIN-BASED TOPICAL OINTMENT FOR TREATMENT OF ACNE, PSORIASIS, EGFR-INDUCED TOXICITY, PREMATURE SKIN AGING AND OTHER SKIN CONDITIONS
#186Taxane- and Taxoid-Protein Compositions
#187Humanized affinity matured anti-FcRn antibodies
#188SELECTIVELY DEGLYCOSYLATED VITAMIN D-BINDING PROTEIN (GCMAF), CHOLECALCIFEROL (CALCIOL), AND PRODUCTION METHOD
#189Methods for providing polymeric synthetic nanocarriers for generating antigen-specific tolerance immune responses
#190Opioid agonist peptides and uses thereof
#191Technology for the Preparation of Microparticles
#192Methods for extracting proteins from a blood-based material
#193Stem cell stimulating compositions and methods of treating melasma
#194Treatment of joint conditions
#195MUTEINS OF TEAR LIPOCALIN AND METHODS FOR OBTAINING THE SAME
#196USE OF DIANHYDROGALACTITOL AND ANALOGS AND DERIVATIVES THEREOF, TOGETHER WITH RADIATION, TO TREAT NON-SMALL-CELL CARCINOMA OF THE LUNG AND GLIOBLASTOMA MULTIFORME AND SUPPRESS PROLIFERATION OF CANCER STEM CELLS
#197Method for the cryopreservation of cells for therapeutic purposes
#198Long-acting GLP-1R agonist as a therapy of neurological and neurodegenerative conditions
#199Method of ameliorating side effects of sickle cell disease treatments
#200MEDICAMENT FOR TREATMENT OF TUMORS AND THE USE THEREOF
#201Compositions derived from Cohn fraction paste and use thereof
#202Engineered primate cystine/cysteine degrading enzymes for therapeutic uses
#203Cationic materials and formulations for drug delivery
#204Glycotargeting therapeutics
#205NKT CELL-ACTIVATION PHARMACEUTICAL COMPOSITION, METHOD FOR PRODUCING THEREOF AND METHOD OF STORING ANTIGEN PRESENTING CELL
#206Diagnosis and treatment of preeclampsia
#207Formulation for targeting cancer in humans and canines
#208Glycotargeting therapeutics
#209METHODS AND PRODUCTS FOR NUCLEIC ACID PRODUCTION AND DELIVERY
#210COMPOSITION FOR SKIN PERMEATION COMPRISING CATIONIC MOLECULAR TRANSPORTER AND PROTEIN
#211Factor IX Polypeptides and Methods of Use Thereof
#212Factor IX polypeptides and methods of use thereof
#213Factor IX Polypeptides and Methods of Use Thereof
#214ALBUMIN FUSION PROTEINS
#215MICROFABRICATED NANOPORE DEVICE FOR SUSTAINED RELEASE OF THERAPEUTIC AGENT
#216Methods of treating epithelioid cell tumors comprising administering a composition comprising nanoparticles comprising an mTOR inhibitor and an albumin
#217METHODS AND COMPOSITIONS FOR TREATING PROLIFERATIVE DISEASES
#218Intravascular delivery of nanoparticle compositions and uses thereof
#219NUTRITIONAL COMPOSITIONS AND INFANT FORMULAS CONTAINING OLIGOFRUCTOSE FOR REDUCING THE LOAD OF PATHOGENIC BACTERIA IN THE GUTS OF INFANTS AND YOUNG CHILDREN
#220Hot flash-suppressing agent
#221Container for a solution of human plasma proteins and method for obtaining thereof
#222Technology for the Preparation of Microparticles
#223Methods and products for nucleic acid production and delivery
#224Albumin nanosphere preparations to control bleeding from surgical operations
#225Preparation method of albumin peptide combination having the action of inhibiting the proliferation of cancer cells
#226FGFR1 EXTRACELLULAR DOMAIN COMBINATION THERAPIES
#227Compositions comprising magnolia, phellodendron, theanine and/or whey protein
#228BIOACTIVE COMPOSITIONS DERIVABLE FROM PLATELET CONCENTRATES, AND METHODS FOR PREPARING AND USING SAME
#229INGESTIBLE FORMULATIONS FOR TRANSIENT, NONINVASIVE REDUCTION OF GASTRIC VOLUME
#230THIOL-ENE FUNCTIONALIZED HYDROGELS
#231Clotting composition
#232Extended-release drug delivery compositions
#233Fusion protein comprising albumin and retinol-binding protein
#234Combination kidney and liver dialysis system and method
#235Compositions and methods of use for treating metabolic disorders
#236Cell-free methods of producing vault particles and vault particles resulting therefrom
#237Treating Lymphomas
#238Methods of treating Mucopolysaccharidosis IIIB (MPSIIIB)
#239NUTRITIONAL SUPPLEMENT FOR USE IN COMBATTING STRESS AND ANXIETY IN PETS
#240Phosphoserine containing compositions for immune tolerance induction
#241METHOD TO REDUCE MUSCLE ATROPHY FOLLOWING ORTHOPEDIC SURGERY
#242Intravascular delivery of nanoparticle compositions and uses thereof
#243Albumin nanoparticles to augment stem cell function in vivo
#244Methods for treating VEGF-expressing cancer using preformed nanoparticle complexes comprising albumin-bound paclitaxel and bevacizumab
#245HALF-LIFE EXTENDED FACTOR FVIIA PROTEIN FOR PREVENTION AND TREATMENT OF BLEEDING AND DOSING REGIMENS THEREFOR
#246Glycotargeting therapeutics
#247Method for the preparation of human albumin with reduced level of dissolved oxygen
#248ALBUMIN NANOPARTICLES TO AUGMENT STEM CELL FUNCTION IN VIVO
#249COMPOSITION INVOLVED IN REGULATING ENERGY CYCLE, INFLAMMATION AND INSULIN RESISTANCE DYSFUNCTIONS, AND USE THEREOF PARTICULARLY IN CARDIOMETABOLIC DISEASES
#250MICROFABRICATED NANOPORE DEVICE FOR SUSTAINED RELEASE OF THERAPEUTIC AGENT
#251Minimizing intestinal dysfunction
#252Methods for treatment of nephrotic syndrome and related conditions
#253Hemostatic compositions
#254Compositions and methods for measuring and expanding blood volume
#255Factor IX polypeptides and methods of use thereof
#256Nutritive polypeptides and formulations thereof, and methods of production and use thereof
#257Cationic materials and formulations for drug delivery
#258Methods and products for nucleic acid production and delivery
#259POLYMER-BASED COMPOSITIONS FOR EXTENDED RELEASE OF PROTEINS
#260Ingestible formulations for transient, noninvasive reduction of gastric volume
#261Multivalent breast cancer vaccine
#262Compositions and formulations for treatment of gastrointestinal tract malabsorption diseases and inflammatory conditions and methods of production and use thereof
#263MICROPARTICLES, BLOOD SUBSTITUTE AND METHOD FOR FORMING SAME
#264REGIMEN AND METHOD FOR TREATMENT OF TYPE 2 DIABETES
#265Tolerogenic synthetic nanocarriers for allergy therapy
#266Factor IX polypeptides and methods of use thereof
#267Muteins of tear lipocalin and methods for obtaining the same
#268TOLEROGENIC SYNTHETIC NANOCARRIERS TO REDUCE IMMUNE RESPONSES TO THERAPEUTIC PROTEINS
#269Tolerogenic synthetic nanocarriers
#270Glycotargeting therapeutics
#271Factor IX polypeptides and methods of use thereof
#272Modified RNA with decreased immunostimulatory properties
#273Method for improving blood persistence of protein
#274Materials and methods for controlling infections
#275Technology for the Preparation of Microparticles
#276Factor IX polypeptides and methods of use thereof
#277TREATMENT OF CONDITIONS RELATED TO SHOCK
#278Hemostatic compositions
#279THERMOLABILE DRUG RELEASE FORMULATION
#280COMPOSITIONS COMPRISING PLANT PROTEINS AND METHODS FOR PREVENTION OF METABOLIC AND CARDIOVASCULAR PATHOLOGIES IN PATIENT WITH CARDIOMETABOLIC RISK, INCLUDING HYPERGLYCEMIA
#281Method of treating patients with hepatorenal syndrome type 1
#282Use of rhodamine dyes to reduce alveolar surface tension
#283Methods and system for interfering with viability of bacteria and related compounds and compositions
#284EGG PROTEIN FORMULATIONS AND METHODS OF MANUFACTURE THEREOF
#285Suppression of cancer metastasis
#286Egg protein formulations and methods of manufacture thereof
#287Biodegradable and clinically-compatible nanoparticles as drug delivery carriers
#288Medical organogel processes and compositions
#289Treatment of joint conditions
#290Method of deriving mature hepatocytes from human embryonic stem cells
#291Tolerogenic synthetic nanocarriers for generating CD8+ regulatory T cells
#292Glycotargeting therapeutics
#293Liquid Factor VIII Formulations
#294Antibacterial agent for treating infectious diseases of bacterial origin
#295EXTENDED-RELEASE DRUG DELIVERY COMPOSITIONS
#296Technology for the Preparation of Microparticles
#297METHOD FOR THE PREPARATION OF HUMAN ALBUMIN WITH REDUCED LEVEL OF DISSOLVED OXYGEN
#298Tolerogenic synthetic nanocarriers for antigen-specific deletion of T effector cells
#299Method for providing polymeric synthetic nanocarriers for generating antigen-specific tolerance immune responses
#300COMPOSITION AND FORMULATION FOR TOPICAL TREATMENT OF INFLAMMATION AND TISSUE DAMAGE